VNRX

Volitionrx

0.35

0.07+24.19%

Pre Market: 0.3548 0.00 0.00%08:59 01/09 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.3490/0.2857

TODAY RANGE0.3250-0.3862

VOL58.22K

MARKET CAP43.57M

52 WEEK RANGE0.2200-0.9400

AVG VOL (3M)2.16M

% TURNOVER12.19%

TURNOVER63.31K

P/E (TTM)-1.5493

% RANGE21.46%

EPS(TTM)-0.2290

P/E(FORWARD)-1.6895

P/B-1.1228

BVPS-0.3160

DIVIDEND--

P/S27.72

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP36.10M

SHARES OUTSTANDING122.80M

NEXT EARNINGS03/30-04/03

FREE FLOAT101.74M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

Dow Jones·1h ago
VolitionRX Price Target Maintained With a $3.00/Share by D. Boral Capital
Seeking Alpha·23h ago
VolitionRx secures $2M financing through amended securities agreement; shares up
PR Newswire·23h ago
VolitionRx Secures $2.0 Million in Funding
Dow Jones·12/18/2025 12:33
VolitionRX Is Maintained at Buy by D. Boral Capital
Dow Jones·12/18/2025 12:33
VolitionRX Price Target Cut to $3.00/Share From $5.00 by D. Boral Capital
TipRanks·12/11/2025 22:29
VolitionRX Announces CEO Departure Amid Cost Realignment
TipRanks·12/11/2025 14:15
VolitionRx announces new paper on Capture-Seq, achieves 180-fold enrichment
PR Newswire·12/11/2025 14:00
Volition Solves Liquid Biopsy's "Needle in a Haystack" Problem; Achieves 180-fold (18,000%) Enrichment
TipRanks·12/05/2025 17:25
VolitionRX Gains Momentum with Strategic Advancements in Sepsis and Cancer Diagnostics
Dow Jones·12/04/2025 18:15
VolitionRX Is Maintained at Buy by D. Boral Capital
Dow Jones·12/04/2025 18:15
VolitionRX Price Target Maintained With a $5.00/Share by D. Boral Capital
PR Newswire·12/04/2025 14:00
VolitionRx Limited Announces Inclusion of its Nu.Q® NETs Assay as Innovative Biomarker in France's Real-World Evaluation of Early Detection of Sepsis
Dow Jones·12/03/2025 19:19
VolitionRX Cut to Hold From Buy by Maxim Group
TipRanks·12/03/2025 13:00
VolitionRx downgraded to Hold from Buy at Maxim

Same Industry

Name/Symbol

Change%

Price

Volitionrx

VNRX

+24.19%

0.3548

Regeneron Pharmaceuticals

REGN

-1.39%

801.01

GridAI Tech

GRDX

-8.32%

4.52

BIONTECH

BNTX

-1.23%

98.85

United Therapeutics Corp.

UTHR

-2.55%

490.83

Vertex Pharmaceuticals Inc

VRTX

-2.99%

469.68

Siga Technologie

SIGA

-1.17%

6.77

Moderna

MRNA

-5.66%

33.86

Charles Riv Labs Intl Inc

CRL

-0.58%

215.51

Medpace Holdings

MEDP

-2.13%

600.02

Talphera Inc

TLPH

-13.49%

1.09

ICON PLC

ICLR

-7.24%

188.22

China Biologic

CBPO

0.00%

119.99

Iqvia Hldgs Inc

IQV

-0.45%

243.19

MOLECULAR PARTNERS AG

MOLN

-0.28%

4.25

Arcturus Therape

ARCT

-1.02%

6.77

Gilead Sciences Inc

GILD

-2.96%

120.67

PRA Health

PRAH

0.00%

165.21

Incyte Corp

INCY

-4.21%

105.92

Aptevo Therapeutics Inc

APVO

+3.31%

9.20

Biospecifics

BSTC

+0.15%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.